GRACE - Genetic Insights Into Early pRegnancy Loss Using Cell-free fEtal DNA
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-43
SponsorRennes University Hospital
About this trial
The aim of this study is to assess the impact of non-invasive prenatal testing right after an early isolated miscarriage on mental health and on the patient's subsequent care in the year following the miscarriage
Eligibility criteria
Qualifiers
A stopped pregnancy with an intrauterine pregnancy diagnosed by ultrasound (embryo larger than 7 mm corresponding to a gestational age of 6 weeks and 5 days. This is justified by the fact that fetal fragment (FF) detection is possible at 5 weeks of gestation, or 7 weeks and 5 days)
Expulsion of a pregnancy within the last 2 hours
Patient fluent in French
Enrolled in a social security program
Disqualifiers
Diagnosis of an empty gestational sac, ectopic pregnancy, or unknown location
Ultrasound findings consistent with a molar pregnancy
Identified cause (preimplantation diagnosis, multiple uterine fibroids or a single fibroid > 5 cm, uterine malformation affecting the uterine cavity, lupus, and antiphospholipid syndrome)
Inability to obtain a blood sample
Trial design
Treatments tested in this trial
- Non invasive prenatal test
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov